Weiss Multi-Strategy Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,000	Closed	-$314K	–	631
2019 Q1	$314K	Buy	+20,000	New	+$353K	0.01%	462
2015 Q2	–	Sell	-10,000	Closed	-$623K	–	525
2015 Q1	$623K	Buy	+10,000	New	+$581K	0.03%	351
2014 Q1	–	Sell	-10,000	Closed	-$401K	–	1120
2013 Q4	$401K	Sell	10,000 -10,000	-50%	-$394K	0.01%	683
2013 Q3	$756K	Buy	+20,000	New	+$780K	0.02%	461

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TEVA Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 503,476 shares — an estimated $5.26M sold.

Weiss Multi-Strategy Advisers first reported a position in TEVA in Q2 2013 and held it in 22 quarters. The position peaked at $7.53M in Q3 2014. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 503,476 Teva Pharmaceuticals shares in Q1 2024, an estimated $5.26M.
Weiss Multi-Strategy Advisers first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 22 quarters.
Weiss Multi-Strategy Advisers's Teva Pharmaceuticals position peaked at $7.53M in Q3 2014.
481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.